Orum Therapeutics, Inc. (KOSDAQ:475830)
91,500
+3,200 (3.62%)
Apr 28, 2026, 3:30 PM KST
258.82% (1Y)
| Market Cap | 1.94T |
| Revenue (ttm) | 23.56M |
| Net Income (ttm) | -41.97B |
| Shares Out | 21.23M |
| EPS (ttm) | -2,017.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 220,255 |
| Average Volume | 215,458 |
| Open | 87,500 |
| Previous Close | 88,300 |
| Day's Range | 85,400 - 91,500 |
| 52-Week Range | 15,950 - 146,600 |
| Beta | n/a |
| RSI | 50.01 |
| Earnings Date | Apr 3, 2026 |